Bio-Rad Laboratories Inc. (BIO) Misses Q1 EPS by 57c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $281.11 -0.47%
Revenue Growth %: -4.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -4.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $0.23, $0.57 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $509 million versus the consensus estimate of $515 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Sun Communities names Ileana McAlary as general counsel and EVP
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
